1.87

6.97% -0.14

Skye Bioscience Inc (SKYE)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$2.01

Offen:

$2.01

24-Stunden-Volumen:

220.56K

Relative Volume:

0.34

Marktkapitalisierung:

$57.93M

Einnahmen:

Nettoeinkommen (Verlust:

$-21.24M

KGV:

-2.2318

EPS:

-0.8379

Netto-Cashflow:

$-22.47M

1W Leistung:

+3.31%

1M Leistung:

+18.35%

6M Leistung:

-62.22%

1J Leistung:

-84.73%

1-Tages-Spanne:

$1.78

$2.03

1-Wochen-Bereich:

$1.78

$2.0998

52-Wochen-Spanne:

$1.14

$12.77

Skye Bioscience Inc Stock (SKYE) Company Profile

Firmenname

Skye Bioscience Inc

Sektor

Healthcare (1170)

Branche

Biotechnology (671)

Telefon

(858) 410-0266

Adresse

11250 EL CAMINO REAL, SUITE 100, SAN DIEGO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

SKYE's Discussions on Twitter

Vergleichen Sie SKYE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SKYE Skye Bioscience Inc.	3.10	12.89M	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.79	372.90M	0	0	0	0.00
JUNE Dhandho Junoon Etf	11.00	215.29M	0	0	0	0.00
SHMD Schmid Group N V	2.87	149.00M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	0.1641	340.19M	2.07B	-1.42B	-1.37B	-0.6765
MOBBW Mobilicom Limited Warrants	0.3476	371.47M	0	0	0	0.00

Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-28	Eingeleitet	William Blair	Outperform
2024-09-30	Eingeleitet	Scotiabank	Sector Outperform
2024-09-10	Eingeleitet	JMP Securities	Mkt Outperform
2024-07-09	Eingeleitet	Craig Hallum	Buy
2024-05-23	Eingeleitet	Cantor Fitzgerald	Overweight
2024-04-12	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Skye Bioscience Inc Aktie (SKYE) Neueste Nachrichten

01:36 AM

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Rating of "Buy" from Brokerages - MarketBeat

01:36 AM

May 15, 2025

Skye Bioscience (NASDAQ:SKYE) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

May 15, 2025

May 14, 2025

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 14, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Rating of “Buy” from Analysts - Defense World

May 14, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives $16.60 Consensus PT from Analysts - Defense World

May 14, 2025

Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) Target Price at $16.60 - Defense World

May 14, 2025

May 13, 2025

Skye Bioscience Awards 100,000 Share Options at $1.82 with 4-Year Vesting Terms - Stock Titan

May 13, 2025

Skye Bioscience (SKYE) Reveals Key Findings on CB1 Inhibitors an - GuruFocus

May 13, 2025

Skye Bioscience Clinical Model Demonstrating Necessity of - GlobeNewswire

May 13, 2025

Skye Bioscience Clinical Model Demonstrating Necessity of Peripheral CB1 Inhibition for Weight Loss Presented at European Congress on Obesity - Stock Titan

May 13, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Bought by Barclays PLC - Defense World

May 13, 2025

Barclays PLC Has $198,000 Stock Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

May 13, 2025

May 12, 2025

Skye Bioscience (SKYE) Receives Adjusted Price Target from Oppen - GuruFocus

May 12, 2025

Oppenheimer cuts Skye Bioscience price target to $17 By Investing.com - Investing.com South Africa

May 12, 2025

Oppenheimer cuts Skye Bioscience price target to $17 - Investing.com

May 12, 2025

Braidwell LP Invests $2.34 Million in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat

May 12, 2025

May 10, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Skye Bioscience, Inc. (SKYE) - ACCESS Newswire

May 10, 2025

May 09, 2025

Earnings call transcript: Skye Bioscience Reports Q1 2025 Financials Amid R&D Expansion - Investing.com Nigeria

May 09, 2025

Skye Bioscience, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SKYE) - Seeking Alpha

May 09, 2025